Journal of advanced research · 2025
Long non-coding RNA antisense of insulin-like growth factor 2 receptor promotes osteogenic differentiation by enhancing runt-related transcription factor 2 translation: A potential therapeutic target for osteoporosis.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhu Jing, Zhao Sicong, Li Xiaoxiu, Wang Jiajun, Zhang Kun, Hong Wei
Аннотация
INTRODUCTION: Osteoporosis is a chronic metabolic disorder characterized by progressive bone loss and increased susceptibility to fractures, for which there is currently no curative treatment that can fully reverse or eliminate the disease.
OBJECTIVES: This study aims to elucidate the regulatory role of antisense of insulin-like growth factor 2 receptor non-protein coding RNA (AIRN) in osteogenesis and the pathogenesis of osteoporosis.
METHODS: Multiple in vivo models of osteoporosis, including tail suspension, ovariectomy, and natural aging, were employed to evaluate the impact of Airn knockout or overexpression on bone formation. A comprehensive array of in vitro assays, including alkaline phosphatase staining, quantitative PCR, Western blotting, bioinformatics analysis, mRNA stability assays, RNA fluorescence in situ hybridization, RNA immunoprecipitation, and luciferase reporter assays, were conducted to investigate the functional mechanisms of AIRN.
RESULTS: We found that Airn is highly enriched in osteogenic lineage cells, significantly upregulated during osteoblast differentiation, and notably downregulated in osteoporotic bone tissue. In vivo, Airn knockout led to impaired bone formation and aggravated bone loss across all three osteoporosis models. Furthermore, AAV9-mediated intratibial overexpression of Airn significantly promoted bone formation and attenuated tail suspension-induced osteoporosis. In vitro, Airn overexpression enhanced the expression of osteogenic marker genes, whereas AIRN knockdown suppressed their expression. Mechanistically, Airn binds to polypyrimidine tract binding protein 1 (PTBP1) and facilitates internal ribosome entry site (IRES)-mediated translation of runt-related transcription factor 2 (Runx2) by enhancing IRES activity within the 5' untranslated region of Runx2 mRNA. Additionally, our data demonstrated that the upregulation of Airn during osteogenic differentiation is orchestrated by RUNX1.
CONCLUSION: Our findings identify Airn as a critical regulator of osteoblast differentiation. Its regulatory effect on Runx2 translation via PTBP1 highlights a novel mechanism underlying osteogenesis and suggests that Airn may serve as a potential therapeutic target for the treatment of osteoporosis.
OBJECTIVES: This study aims to elucidate the regulatory role of antisense of insulin-like growth factor 2 receptor non-protein coding RNA (AIRN) in osteogenesis and the pathogenesis of osteoporosis.
METHODS: Multiple in vivo models of osteoporosis, including tail suspension, ovariectomy, and natural aging, were employed to evaluate the impact of Airn knockout or overexpression on bone formation. A comprehensive array of in vitro assays, including alkaline phosphatase staining, quantitative PCR, Western blotting, bioinformatics analysis, mRNA stability assays, RNA fluorescence in situ hybridization, RNA immunoprecipitation, and luciferase reporter assays, were conducted to investigate the functional mechanisms of AIRN.
RESULTS: We found that Airn is highly enriched in osteogenic lineage cells, significantly upregulated during osteoblast differentiation, and notably downregulated in osteoporotic bone tissue. In vivo, Airn knockout led to impaired bone formation and aggravated bone loss across all three osteoporosis models. Furthermore, AAV9-mediated intratibial overexpression of Airn significantly promoted bone formation and attenuated tail suspension-induced osteoporosis. In vitro, Airn overexpression enhanced the expression of osteogenic marker genes, whereas AIRN knockdown suppressed their expression. Mechanistically, Airn binds to polypyrimidine tract binding protein 1 (PTBP1) and facilitates internal ribosome entry site (IRES)-mediated translation of runt-related transcription factor 2 (Runx2) by enhancing IRES activity within the 5' untranslated region of Runx2 mRNA. Additionally, our data demonstrated that the upregulation of Airn during osteogenic differentiation is orchestrated by RUNX1.
CONCLUSION: Our findings identify Airn as a critical regulator of osteoblast differentiation. Its regulatory effect on Runx2 translation via PTBP1 highlights a novel mechanism underlying osteogenesis and suggests that Airn may serve as a potential therapeutic target for the treatment of osteoporosis.